Prosecution Insights
Last updated: April 19, 2026

Examiner: PULLIAM, JOSEPH CONSTANTINE

Tech Center 1600 • Art Units: 1671 1682 1687

This examiner grants 38% of resolved cases

Performance Statistics

38.0%
Allow Rate
-22.0% vs TC avg
84
Total Applications
+30.9%
Interview Lift
1908
Avg Prosecution Days
Based on 50 resolved cases, 2023–2026

Rejection Statute Breakdown

33.0%
§101 Eligibility
4.4%
§102 Novelty
24.1%
§103 Obviousness
29.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17295098 ASSESSING GUT HEALTH USING METAGENOME DATA Non-Final OA Mayo Foundation for Medical Education and Research
18011687 METHODS AND COMPOSITIONS FOR THE MOLECULAR DIAGNOSIS OF MICROSATELLITE INSTABILITY AND TREATMENTS FOR CANCER Non-Final OA UNIVERSITY OF WASHINGTON
17272383 DETECTION METHOD AND DETECTION APPARATUS FOR GENOMIC STRUCTURAL VARIATIONS BASED ON K-MER SET IN REFERENCE GENOME Final Rejection INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
17332951 Systems and Methods for Determining Molecular Properties with Atomic-Orbital-Based Features Non-Final OA Iambic Therapeutics, Inc.
17186163 THYMIDINE KINASE (TK-1) IN PROGNOSTIC INDICES FOR DLBCL Final Rejection Roche Diagnostics Operations, Inc.
18734907 BIOLOGICAL STRUCTURE TOKENIZER Non-Final OA EvolutionaryScale, PBC
18397993 GENERATIVE ATOMISTIC DESIGN OF MATERIALS Non-Final OA Quantum Generative Materials LLC
17293923 METHOD OF TESTING AND FITTING THE DIHEDRAL ANGLE PARAMETERS IN FORCE FIELD Final Rejection SHENZHEN JINGTAI TECHNOLOGY CO., LTD.
17068546 IMMUNE RECEPTOR ANALYSIS AS DIAGNOSTIC ASSAY Final Rejection Saint Louis University
17871853 USING CELL-FREE DNA FRAGMENT SIZE TO DETERMINE COPY NUMBER VARIATIONS Non-Final OA Verinata Health, Inc.
17920109 MULTI-GENE EXPRESSION ASSAY FOR PROSTATE CARCINOMA Non-Final OA UNIVERSITÄT LEIPZIG
18023581 METHOD OF ASSESSING THE CIRCADIAN RHYTHM OF A SUBJECT HAVING CANCER AND/OR ASSESSING A TIMING OF ADMINISTRATION OF A MEDICAMENT TO SAID SUBJECT HAVING CANCER Non-Final OA Angela MOREIRA BORRALHO RELÓGIO
17420582 METHOD AND SYSTEM FOR PREDICTING DRUG BINDING USING SYNTHETIC DATA Non-Final OA CYCLICA INC.
17242145 METHODS OF IDENTIFYING TREATMENTS USING DIFFERENTIALLY EXPRESSED GENES Final Rejection Advaita Corporation
17259518 METHODS AND SYSTEMS FOR PROCESSING SAMPLES Non-Final OA IDBYDNA INC.
17108980 METHODS FOR FINGERPRINTING OF BIOLOGICAL SAMPLES Final Rejection Lexent Bio, Inc.
17057432 METHODS TO IDENTIFY STRUCTURAL VARIATIONS THAT CAUSE DISEASES AND THE REGIONS TO REPAIR WITH GENE EDITING Final Rejection Williwaw Biosciences LLC
16960767 SYSTEMS AND METHODS FOR DISTRIBUTING CELL THERAPIES Non-Final OA Atara Biotherapeutics, Inc.
16533676 MULTI-MODAL APPROACH TO PREDICTING IMMUNE INFILTRATION BASED ON INTEGRATED RNA EXPRESSION AND IMAGING FEATURES Non-Final OA TEMPS AI, INC.
16096997 Machine Learning Algorithm for Identifying Peptides that Contain Features Positively Associated with Natural Endogenous or Exogenous Cellular Processing, Transportation and Histocompatibility Complex (MHC) Presentation Non-Final OA ONCOIMMUNITY AS

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month